Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: A report of the southwest pediatric nephrology study group

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 2, 1999, Pages 596-601

  Powell, David R ^a,f   Durham, Susan K ^a   Brewer, Eileen D ^a   Frane, James W ^b   Watkins, Sandra L ^c   Hogg, Ronald J ^d   Mohan, Subburaman ^e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Cleft Lip and Palate Treatm Center   (United States)

^e LOMA LINDA UNIVERSITY   (United States)

^f TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5;

ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; GROWTH HORMONE BLOOD LEVEL; HUMAN; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY;

BODY HEIGHT; CHILD; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KIDNEY FAILURE, CHRONIC;

EID: 0033054237     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.2.596     Document Type: Article

References (45)

1. 1. Powell DR. 1989 Renal disease and growth retardation. Kidney. 22:7-12.
2. 2. Powell DR. 1997 The effects of renal failure on the growth hormone/insulin-like growth factor axis. J Pediatr. 131:S13-S16.
3. 3. El-Bishti M, Counahan R, Bloom S, Chantler C. 1978 Hormonal and metabolic responses to intravenous glucose in children on regular hemodialysis. Am J Clin Nutr. 31:1865-1869.
4. 4. Powell DR, Rosenfeld RG, Baker BK, Hintz RL. 1986 Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor (IGF)-I and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab. 63:1186-1192.
5. 5. Powell DR, Rosenfeld RG, Sperry JB, Baker BK, Hintz RL. 1987 Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis. 10:287-292.
6. 6. Phillips LS, Fusco AC, Unterman TG, DelGreco F. 1984 Somatomedin inhibitor in uremia. J Clin Endocrinol Metab. 59:764-772.
7. 7. Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O. 1991 Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol. 5:539-544.
8. 8. Powell DR, Liu F, Baker B, Lee PDK, Belsha CW, Brewer ED, Hintz RL. 1993 Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res. 33:136-143.
9. 9. Baxter RC, Martin JL. 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest. 78:1504-1512.
10. 10. Blum WF, Horn N, Kratzsch J, et al. 1993 Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul. 3:100-104.
11. 11. Tonshoff B, Blum WF, Wingen A-M, Mehls O. 1995 Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2 and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. J Clin Endocrinol Metab. 80:2684-2691.
12. 12. Powell DR, Liu F, Baker BK, et al. 1997 Modulation of growth factors by growth hormone in children with chronic renal failure. Kidney Int. 51:1970-1979.
13. 13. Tonshoff B, Blum WF, Mehls O. 1996 Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease. Pediatr Nephrol. 10:269-274.
14. 14. Powell DR, Liu F, Baker BK, et al. 1997 Insulin-like growth factor binding protein-6 levels are elevated in serum of children with chronic renal failure. J Clin Endocrinol Metab. 82:2978-2984.
15. 15. Powell DR, Durham SK, Liu F, et al. 1998 The IGF axis and growth in children with chronic renal failure. J Clin Endocrinol Metab. 83:1654-1661.
16. 16. Shimasaki S, Shimonaka M, Zhang H-P, Ling N. 1991 Identification of five different IGFBPs from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem. 266:10646-10653.
17. 17. Shimasaki S, Gao L, Shimonaka M, Ling N. 1991 Isolation and molecular cloning of insulin-like growth factor binding protein-6. Mol Endocrinol. 5:938-948.
18. 18. Cox GN, McDermott MJ, Merkel E, et al. 1994 Recombinant human insulin-like growth factor (IGF) binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology. 135:1913-1920.
19. 19. Burch WM, Correa J, Shively JE, Powell DR. 1990 The 25 kiloDalton insulin-like growth factor (IGF) binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro. J Clin Endocrinol Metab. 70:173-180.
20. 20. Rajkumar K, Barron D, Lewitt MS, Murphy LJ. 1995 Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology. 136:4029-4034.
21. 21. Gay E, Seurin D, Babajko S, Doublier S, Cazillis M, Binoux M. 1997 Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante-and perinatal mortality and postnatal growth. Endocrinology. 138:2937-2947.
22. 22. Kale AS, Liu F, Hintz RL, et al. 1996 Characterization of insulin-like growth factors (IGFs) and IGF binding proteins in peritoneal dialysate. Pediatr Nephrol. 10:467-473.
23. 23. Durham SK, Mohan S, Liu F, et al. 1997 Bioactivity of a 29 kD IGFBP-3 fragment present in excess in chronic renal failure serum. Pediatr Res. 42:335-341.
24. 24. Shilitz P, Mohan S, Baylink DJ. 1993 Insulin-like growth factor binding protein-4 inhibits both basal and IGF-mediated chick pelvic cartilage growth in vitro. J Bone Miner Res. 8:391-396.
25. 25. Mohan S, Bautista C, Wergedal J, Baylink DJ. 1989 Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell conditioned medium: a potential local regulator of IGF action. Proc Natl Acad Sci USA. 86:8338-8342.
26. 26. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-34.
27. 27. Mohan S, Nakao Y, Honda Y, et al. 1995 Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (TGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem. 270:20424-20431.
28. 28. Andress DL, Birnbaum RS. 1991 A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells. Biochem Biophys Res Commun. 176:213-218.
29. 29. Bautista CM, Baylink DJ, Mohan S. 1991 Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun. 176:756-763.
30. 30. Andress DL, Loop SM, Zapf J, Kiefer MC. 1993 Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun. 195:25-30.
31. 31. Jones JI, Busby WH, Gockerman A, Comacho-Hubner C, Clemmons DR. 1992 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol. 121:679-687.
32. 32. Liu X-J, Malkowski M, Guo Y, Erickson GF, Shimasaki S, Ling N. 1993 Development of specific antibodies to rat insulin-like growth factor binding proteins (IGFBP-2 to -6): analysis of IGFBP production by rat granulosa cells. Endocrinology. 132:1176-1183.
33. 33. Honda Y, Landale EC, Strong DD, Baylink DJ, Mohan S. 1996 Recombinant synthesis of insulin-like growth factor binding protein-4 (IGFBP-4): development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocrinol Metab. 81:1389-1396.
34. 34. Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S. 1997 Insulin-like growth factor (IGF)-I, IGF binding proteins (IGFBP)-3, -4 and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. J Bone Miner Res. 12:423-430.
35. 35. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink DJ. 1995 Development, validation and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab. 80:2638-2645.
36. 36. Ono T, Kanzani S, Seino Y, Baylink DJ, Mohan S. 1996 Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme. J Clin Endocrinol Metab. 81:2111-2116.
37. 37. Kiefer MC, Schmid C, Waldvogel M, et al. 1992 Characterization of recombinant human insulin-like growth factor binding proteins 4, 5 and 6 produced in yeast. J Biol Chem. 267:12692-12699.
38. 38. Mohan S. 1993 Insulin-like growth factor binding proteins in bone cell regulation. Growth Regul. 3:65-68.
39. 39. Daughaday WH, Rotwein P. 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev. 10:68-91.
40. 40. Lee PDK, Durham SK, Martinez V, Vasconez O, Powell DR, Guevarra-Aguirre J. 1997 Kinetics of insulin-like growth factor (IGF) and IGF binding protein responses to a single dose of growth hormone. J Clin Endocrinol Metab. 82:2266-2274.
41. 41. Baxter RC. 1990 Circulating levels and molecular distribution of the acid-labile (α) subunit of the high molecular weight insulin-like growth factor binding protein complex. J Clin Endocrinol Metab. 70:1347-1353.
42. 42. Guler H-P, Zapf J, Schmid C, Froesch ER. 1990 Insulin-like growth factor I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh). 121:753-758.
43. 43. Twigg SM, Baxter RC. 1998 Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. J Biol Chem. 273:6074-6079.
44. 44. Booth BA, Boes M, Andress DL, et al. 1995 IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Growth Regul. 5:1-7.
45. 45. Schuller AGP, Pintar JE. Embryonic growth deficit in IGFBP-4 deficient mice. Proc of the 80th Annual Meet of The Endocrine Soc. 1998; 59-60.